Company news
Keymed Biosciences, Inc. news in 2026
Keymed Biosciences, Inc.'s news releases, calls and decks from 2026, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 2, 2026
Voluntary announcement - share purchase pursuant to the 2022 restricted share unit scheme
October 29, 2026
Inside information announcement-(1) update on product revenue for the first three quarters of 2026 and (2) national medical products administration approves the new indication marketing application for Stapokibart for the treatment of moderate-to-severe atopic dermatitis in adolescents
October 15, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 5, 2026
2026 Interim report
September 22, 2026
Keymed Biosciences Announces 2026 H1 Results and Business Updates
August 20, 2026
Keymed Biosciences Announces 2025 Annual Results and Business Updates
March 26, 2026